GRIK1 and epilepsy: Some researchers showed that selective agonists of kainate receptors containing GluK1 induce seizure activity in preclinical models of epilepsy and observed that GluK1 knock-out mice exhibited reduced thresholds for behavioral arrest and clonic seizures (Fritsch et al., 2014).